A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation
Giovanna Bergamini(Heidelberg Engineering (Germany)), Gitte Neubauer, Toby Mathieson, Jessica Perrin(GlaxoSmithKline (Germany)), Carola Doce(GlaxoSmithKline (Germany)), Thilo Werner(GlaxoSmithKline (Germany)), Kathryn M. Bell(CellCentric (United Kingdom)), Alison O’Mahony(Goldfinch Bio (United States)), Nigel G. Ramsden(CellCentric (United Kingdom)), Oliver Rausch(Mission Therapeutics (United Kingdom)), Faı̈za Rharbaoui, Carsten Hopf(Technische Hochschule Mannheim), Marcus Bantscheff(Roche (Switzerland)), Christina Rau(GlaxoSmithKline (Germany)), Daniel Leggate(CellCentric (United Kingdom)), Ivan Plavec(Genesys (United States)), Andrew D. Cansfield(CellCentric (United Kingdom)), Katie Ellard(CellCentric (United Kingdom)), Gerard Drewes(Unknown), Friedrich Reinhard(GlaxoSmithKline (Germany)), Emilio Hirsch(University of Turin), Raffaella Mangano(CellCentric (United Kingdom)), Mikhail M. Savitski(European Molecular Biology Laboratory), K. H. Müller, Satoko Shimamura
Cited by 146
Related Papers
Mass-spectrometry-based draft of the human proteome
|Nature|2014|1.9k
Quantitative mass spectrometry in proteomics: a critical review
|Analytical and Bioanalytical Chemistry|2007|1.7k
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present
|Analytical and Bioanalytical Chemistry|2012|801